HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

CD10-positive malignant spindle cell tumor of the lip in a child: a malignant myoepithelioma?

Abstract
A 9-year-old girl consulted to our hospital because of lower lip tumor. Excision of the tumor was performed. Histologically, the tumor consisted of cellular spindle and round cells with hyperchromatic nuclei and nucleoli. Mitotic figure and apoptotic bodies were scattered. Immunohistochemically, the tumor cells were strongly and diffusely positive for CD10 and vimentin. The tumor was focally positive for S100 protein, α-smooth muscle actin, PDGFRA, HER2/neu, p53, and CD68. The Ki-67 labeling was 20%. In contrast, the tumor cells were negative for pancytokeratins (AE1/3, CAM5.2, WSS, KL-1, HNF116), cytokeratin (CK) 5/6, CK34βE12, CK7, CK8, CK14, CK18, CK19, CK20, EMA, desmin, CD34, melanosome, KIT, p63, myoglobin, CD45, CD56, GFAP, D2-40, CEA and synaptophysin. The Histologies, positive p53 protein, and Ki-67 labeling of 20% suggested low grade malignancy. Although histological type was unclear, the author diagnosed this tumor as malignant myoepithelioma arising from the lip minor salivary gland because of positive reaction for S100 protein, α-smooth muscle actin, and CD10. The patient is now free from tumor 8 years after the first presentation.
AuthorsTadashi Terada
JournalInternational journal of clinical and experimental pathology (Int J Clin Exp Pathol) Vol. 6 Issue 5 Pg. 978-81 ( 2013) ISSN: 1936-2625 [Electronic] United States
PMID23638234 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Biomarkers, Tumor
  • Neprilysin
Topics
  • Biomarkers, Tumor (analysis)
  • Child
  • Female
  • Humans
  • Immunohistochemistry
  • Lip Neoplasms (metabolism, pathology)
  • Myoepithelioma (metabolism, pathology)
  • Neprilysin (biosynthesis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: